Medical Research Council, Centre for Transplantation, King's College London, King's Health Partners, Guy's Hospital, London, United Kingdom.
PLoS One. 2011;6(10):e25857. doi: 10.1371/journal.pone.0025857. Epub 2011 Oct 17.
Regulatory T cells (Tregs) were identified several years ago and are key in controlling autoimmune diseases and limiting immune responses to foreign antigens, including alloantigens. In vivo imaging techniques including intravital microscopy as well as whole body imaging using bioluminescence probes have contributed to the understanding of in vivo Treg function, their mechanisms of action and target cells. Imaging of the human sodium/iodide symporter via Single Photon Emission Computed Tomography (SPECT) has been used to image various cell types in vivo. It has several advantages over the aforementioned imaging techniques including high sensitivity, it allows non-invasive whole body studies of viable cell migration and localisation of cells over time and lastly it may offer the possibility to be translated to the clinic. This study addresses whether SPECT/CT imaging can be used to visualise the migratory pattern of Tregs in vivo. Treg lines derived from CD4(+)CD25(+)FoxP3(+) cells were retrovirally transduced with a construct encoding for the human Sodium Iodide Symporter (NIS) and the fluorescent protein mCherry and stimulated with autologous DCs. NIS expressing self-specific Tregs were specifically radiolabelled in vitro with Technetium-99m pertechnetate ((99m)TcO(4)(-)) and exposure of these cells to radioactivity did not affect cell viability, phenotype or function. In addition adoptively transferred Treg-NIS cells were imaged in vivo in C57BL/6 (BL/6) mice by SPECT/CT using (99m)TcO(4)(-). After 24 hours NIS expressing Tregs were observed in the spleen and their localisation was further confirmed by organ biodistribution studies and flow cytometry analysis. The data presented here suggests that SPECT/CT imaging can be utilised in preclinical imaging studies of adoptively transferred Tregs without affecting Treg function and viability thereby allowing longitudinal studies within disease models.
调节性 T 细胞(Tregs)是几年前被发现的,它们在控制自身免疫性疾病和限制对外来抗原(包括同种抗原)的免疫反应方面起着关键作用。包括活体显微镜在内的活体成像技术以及使用生物发光探针的全身成像技术,有助于理解 Treg 的体内功能、作用机制和靶细胞。通过单光子发射计算机断层扫描(SPECT)对人钠/碘转运体的成像已被用于体内各种细胞类型的成像。它与上述成像技术相比具有几个优势,包括高灵敏度、允许对活细胞迁移进行非侵入性的全身研究以及随时间推移对细胞的定位,最后它可能具有转化为临床的可能性。本研究旨在探讨 SPECT/CT 成像是否可用于体内可视化 Treg 的迁移模式。Treg 系由 CD4(+)CD25(+)FoxP3(+)细胞经逆转录病毒转导编码人钠碘转运体(NIS)和荧光蛋白 mCherry 的构建体而获得,并与自体树突细胞刺激。体外用放射性核素锝-99m 高锝酸盐((99m)TcO(4)(-))特异性放射性标记表达 NIS 的自身特异性 Treg,这些细胞暴露于放射性物质不会影响细胞活力、表型或功能。此外,通过 SPECT/CT 用 (99m)TcO(4)(-)对体内 C57BL/6(BL/6)小鼠中的过继转移 Treg-NIS 细胞进行成像。24 小时后,在脾脏中观察到表达 NIS 的 Treg,通过器官生物分布研究和流式细胞术分析进一步证实了其定位。这里提出的数据表明,SPECT/CT 成像可用于过继转移 Treg 的临床前成像研究,而不会影响 Treg 的功能和活力,从而允许在疾病模型中进行纵向研究。